← back to search

Li Tee Tan

Ningbo University · CN
Area of research
Obstetrics and Gynecology · Radiation
Research interest
Research interests include Endometrial and Cervical Cancer Treatments, Advanced Radiotherapy Techniques, Advances in Oncology and Radiotherapy, and Cervical Cancer and HPV Research.
h-index
34
citations
5,931
works
167
NIH funding
primary concept
Medicine
email

Recent publications

Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
2023cited by 55position: contributordoi
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
The Lancet Oncology 2021cited by 619position: middledoi
Metrics to evaluate the performance of auto-segmentation for radiation treatment planning: A critical review
Radiotherapy and Oncology 2021cited by 222position: middledoi
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
International Journal of Radiation Oncology*Biology*Physics 2021cited by 46position: middledoi
Nomogram Predicting Overall Survival in Patients With Locally Advanced Cervical Cancer Treated With Radiochemotherapy Including Image-Guided Brachytherapy: A Retro-EMBRACE Study
International Journal of Radiation Oncology*Biology*Physics 2021cited by 46position: middledoi
Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
Frontiers in Immunology 2021cited by 35position: middledoi
Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future
International Journal of Radiation Oncology*Biology*Physics 2021cited by 34position: middledoi
Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging – An analysis from the EMBRACE study
Gynecologic Oncology 2020cited by 43position: middledoi
Could Radiotherapy with Simultaneous Integrated Boost (SIB) Become the New Standard in the Treatment of Advanced Esophageal Cancer?
International Journal of Radiation Oncology*Biology*Physics 2019cited by 0position: middledoi
New paradigms for <i>BRCA1</i>/<i>BRCA2</i> testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study
Journal of Medical Genetics 2016cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Richard Pötter · Advanced Centre for Treatment, Research and Education in Cancer4 papers (2020–2023)Erik Van Limbergen · Janssen (Belgium)3 papers (2020–2021)Umesh Mahantshetty · Cancer Hospital and Research Institute3 papers (2020–2021)Jacob Christian Lindegaard · Aarhus University Hospital3 papers (2021–2023)Maximilian Schmid · Medical University of Vienna3 papers (2020–2023)Lars Fokdal · Region of Southern Denmark3 papers (2020–2021)Barbara Šegedin · University of Ljubljana3 papers (2020–2021)Alina Sturdza · Vienna General Hospital3 papers (2020–2021)Christine Haie-Méder · Institut Gustave Roussy3 papers (2020–2021)Elzbieta van der Steen-Banasik · Radiotherapie Groep2 papers (2020–2021)Bhavana Rai · Creative Commons2 papers (2020–2021)Rachel Cooper · Leeds Teaching Hospitals NHS Trust2 papers (2020–2021)Bradley R. Pieters · Dutch Cancer Society2 papers (2020–2023)Ericka Wiebe · Sunnybrook Health Science Centre2 papers (2020–2021)Peter Hoskin · Manchester Academic Health Science Centre2 papers (2020–2021)Remi A. Nout · Erasmus MC2 papers (2020–2021)Ina M. Jürgenliemk‐Schulz · Utrecht University2 papers (2021–2021)Kjersti Bruheim · Akershus University Hospital2 papers (2020–2021)Kathrin Kirchheiner · Ludwig Boltzmann Institute for Digital Health and Prevention2 papers (2021–2021)Marit Sundset · St Olav's University Hospital2 papers (2020–2021)